PL1879560T3 - Stały przezskórny układ terapeutyczny z pochłaniaczem UV - Google Patents

Stały przezskórny układ terapeutyczny z pochłaniaczem UV

Info

Publication number
PL1879560T3
PL1879560T3 PL06753441T PL06753441T PL1879560T3 PL 1879560 T3 PL1879560 T3 PL 1879560T3 PL 06753441 T PL06753441 T PL 06753441T PL 06753441 T PL06753441 T PL 06753441T PL 1879560 T3 PL1879560 T3 PL 1879560T3
Authority
PL
Poland
Prior art keywords
absorber
therapeutic system
transdermal therapeutic
solid transdermal
solid
Prior art date
Application number
PL06753441T
Other languages
English (en)
Inventor
Thomas Langguth
Stefan Bracht
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL1879560T3 publication Critical patent/PL1879560T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06753441T 2005-05-02 2006-04-28 Stały przezskórny układ terapeutyczny z pochłaniaczem UV PL1879560T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber
PCT/EP2006/003959 WO2006117139A2 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber
EP06753441.2A EP1879560B1 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber

Publications (1)

Publication Number Publication Date
PL1879560T3 true PL1879560T3 (pl) 2015-02-27

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06753441T PL1879560T3 (pl) 2005-05-02 2006-04-28 Stały przezskórny układ terapeutyczny z pochłaniaczem UV

Country Status (26)

Country Link
EP (2) EP1719504A1 (pl)
JP (2) JP5360877B2 (pl)
KR (2) KR101351161B1 (pl)
CN (2) CN108969507A (pl)
AR (1) AR055927A1 (pl)
AU (1) AU2006243442A1 (pl)
BR (1) BRPI0611087A2 (pl)
CA (1) CA2605112C (pl)
CR (1) CR9483A (pl)
CY (1) CY1115757T1 (pl)
DK (1) DK1879560T3 (pl)
DO (1) DOP2006000100A (pl)
EA (1) EA200702344A1 (pl)
ES (1) ES2523663T3 (pl)
GT (1) GT200600183A (pl)
IL (1) IL186945A0 (pl)
MX (1) MX2007013779A (pl)
NO (1) NO20076187L (pl)
PE (1) PE20061414A1 (pl)
PL (1) PL1879560T3 (pl)
PT (1) PT1879560E (pl)
SI (1) SI1879560T1 (pl)
TW (1) TW200719902A (pl)
UY (1) UY29511A1 (pl)
WO (1) WO2006117139A2 (pl)
ZA (1) ZA200710418B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100704825B1 (ko) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 Uv 안정성 경피 치료 플라스터
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2012031999A2 (en) 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
EP0453396B1 (de) * 1990-03-30 1995-12-13 Ciba SC Holding AG Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
EP1269999B1 (en) * 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
KR100704825B1 (ko) 2003-02-21 2007-04-09 바이엘 쉐링 파마 악티엔게젤샤프트 Uv 안정성 경피 치료 플라스터
WO2005023878A1 (en) * 2003-09-11 2005-03-17 Ciba Specialty Chemicals Holding Inc. Water based concentrated product forms of light stabilizers made by a heterophase polymerization technique

Also Published As

Publication number Publication date
WO2006117139A2 (de) 2006-11-09
ZA200710418B (en) 2009-08-26
MX2007013779A (es) 2008-01-22
KR101426218B1 (ko) 2014-08-05
DOP2006000100A (es) 2007-01-31
IL186945A0 (en) 2008-02-09
KR101351161B1 (ko) 2014-01-14
WO2006117139A3 (de) 2007-04-19
JP5360877B2 (ja) 2013-12-04
UY29511A1 (es) 2006-08-31
CA2605112C (en) 2013-11-05
CA2605112A1 (en) 2006-11-09
CR9483A (es) 2008-01-21
TW200719902A (en) 2007-06-01
KR20130099203A (ko) 2013-09-05
GT200600183A (es) 2007-01-03
ES2523663T3 (es) 2014-11-28
AU2006243442A1 (en) 2006-11-09
DK1879560T3 (en) 2014-11-24
CN108969507A (zh) 2018-12-11
SI1879560T1 (sl) 2015-01-30
CY1115757T1 (el) 2017-01-25
BRPI0611087A2 (pt) 2010-08-03
NO20076187L (no) 2007-11-30
JP2013177451A (ja) 2013-09-09
PT1879560E (pt) 2014-11-19
CN101171001A (zh) 2008-04-30
AR055927A1 (es) 2007-09-12
KR20080003854A (ko) 2008-01-08
PE20061414A1 (es) 2007-01-26
EP1879560B1 (de) 2014-08-27
EP1719504A1 (de) 2006-11-08
EP1879560A2 (de) 2008-01-23
JP2008540352A (ja) 2008-11-20
EA200702344A1 (ru) 2008-12-30

Similar Documents

Publication Publication Date Title
ZA200803882B (en) Transdermal Therapeutic System
PT3424932T (pt) Boronoftalidas para utilização terapêutica
GB0526291D0 (en) Therapeutic method
ZA200803032B (en) Ultraviolet radiation treatment system
SI1877096T1 (sl) Terapija ledvičnih kamnov brez litotripsije
GB0521139D0 (en) Therapeutic agent
GB0615545D0 (en) Therapeutic agent
GB0515140D0 (en) Therapeutic device
ZA200809004B (en) Autodestructive transdermal therapeutic system
ZA200709627B (en) Combination therapy
GB0504206D0 (en) Combination therapy
ZA200710418B (en) Solid transdermal therapeutic system comprising UV absorber
GB0509052D0 (en) Combination therapy
GB0507003D0 (en) Therapeutic
GB0518720D0 (en) Therapeutic combination
GB0508153D0 (en) Therapeutic agent
GB0511259D0 (en) Therapeutic utrasound system
HK1120435A (en) Transdermal therapeutic system
GB0521207D0 (en) Effluent treatment
GB0511539D0 (en) Effluent treatment
GB0514347D0 (en) Combination therapy
GB0526132D0 (en) Combination Therapy
GB0500659D0 (en) Combination therapy
GB0513778D0 (en) Combination therapy
GB0526121D0 (en) Combination therapy